Notes And Other Explanatory Information [Abstract]

Innate Pharma - Filing #2813423

Concept	2022-01-01 to 2022-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]	Estimations et jugements comptables déterminants
Disclosure of auditors' remuneration [text block]
Disclosure of authorisation of financial statements [text block]	Ils seront approuvés par l’Assemblée générale de la Société du
Disclosure of basis of preparation of financial statements [text block]	Base de préparation
Disclosure of changes in accounting policies [text block]	Normes comptables et interprétations récemment émises
Disclosure of commitments and contingent liabilities [text block]	Engagements, passifs éventuels et litiges
Disclosure of credit risk [text block]
Disclosure of deferred taxes [text block]
Disclosure of depreciation and amortisation expense [text block]
Disclosure of discontinued operations [text block]	Activités abandonnées
Disclosure of earnings per share [text block]	Résultat par action
Disclosure of employee benefits [text block]	Avantages au personnel
Disclosure of events after reporting period [text block]	Événements postérieurs à la clôture
Disclosure of expenses by nature [text block]	Charges opérationnelles courantes
Disclosure of fair value of financial instruments [text block]
Disclosure of financial instruments [text block]	Trésorerie, équivalents de trésorerie et actifs financiers
Disclosure of financial risk management [text block]	Gestion des risques financiers et juste valeur
Disclosure of government grants [text block]	Financements publics de dépenses de recherche
Disclosure of impairment of assets [text block]
Disclosure of income tax [text block]	Impôts sur les bénéfices
Disclosure of information about key management personnel [text block]
Disclosure of interest expense [text block]	Résultat financier (net)
Disclosure of issued capital [text block]	Capital social
Disclosure of leases [text block]	Passifs financiers
Disclosure of liquidity risk [text block]
Disclosure of market risk [text block]
Disclosure of other liabilities [text block]
Disclosure of other operating expense [text block]
Disclosure of other provisions, contingent liabilities and contingent assets [text block]	Passifs éventuels et litiges
Disclosure of property, plant and equipment [text block]	Immobilisations corporelles
Disclosure of research and development expense [text block]
Disclosure of revenue [text block]	Produits opérationnels et financements publics
Disclosure of revenue from contracts with customers [text block]
Disclosure of share capital, reserves and other equity interest [text block]	Capital
Disclosure of share-based payment arrangements [text block]	Paiements en actions
Disclosure of subsidiaries [text block]	Méthode de consolidation
Disclosure of trade and other payables [text block]	Dettes opérationnelles
Disclosure of trade and other receivables [text block]	Créances courantes et non courantes
Disclosure of treasury shares [text block]